OSCR

Expression of GPR34 in microglia remains stable in human Alzheimer's disease.

Overview

Authors: Sophie Seiffer1, Jonas Rotter1, Jana Brendler1, Albert Ricken1, Zoe Detzer1, Max Braune2, Torsten Schöneberg3,4, Angela Schulz3, Karsten Winter1, Ingo Bechmann1,5
  1. Institute of Anatomy, Faculty of Medicine, Leipzig University, Liebigstraße 13, 04103 Leipzig, Germany
  2. Paul Flechsig Institute of Neuropathology, University Hospital Leipzig, Leipzig, Germany
  3. Rudolf Schönheimer Institute of Biochemistry, Faculty of Medicine, Leipzig University, Leipzig, Germany
  4. Department of Biochemistry, School of Medicine, University of Global Health Equity (UGHE), Kigali, Rwanda
  5. LeiCeM - Leipzig Center of Metabolism, Leipzig University, Leipzig, Germany
Journal: Acta neuropathologica, volume 151, issue 1, article 66
Dates: received 8 February 2026; accepted 22 May 2026; published online 15 June 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1007/s00401-026-03035-0 · PMID 42295430 · PMCID PMC13269318 · OpenAlex W7164834015
Open access: hybrid, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: histology / microscopy (modality), human (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics, Preprocessing, Connectivity, fMRI & imaging
Keywords: Neuropathology, Neurodegenerative disease, Glia, Neurofibrillary tangles, Amyloid beta plaques
MeSH: Alzheimer Disease*, Microglia*, Receptors, Lysophospholipid*, Temporal Lobe*, Aged, Aged, 80 and over, Amyloid beta-Peptides, Female, Humans, Male, Plaque, Amyloid, tau Proteins (* major topic)
Topic: Neuroinflammation and Neurodegeneration Mechanisms (Neurology, Neuroscience), according to OpenAlex
Funding: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Germany´s Excellence Strategy (EXC-3105/1-533765739)
Citations: not cited yet (Europe PMC); 134 references in the paper

Abstract

Microglia are the resident immune cells of the human central nervous system and play key roles in development, homeostasis, and disease. These functions are mediated by a broad repertoire of cell-surface receptors, including G protein-coupled receptors such as the ADP receptor P2Y12 and GPR34, a receptor for lysophosphatidylserine. While GPR34 deficiency has been linked to impaired microglial phagocytosis, its regulation in relation to amyloid-β (Aβ) and tau pathology in Alzheimer’s disease (AD) remains unclear. We performed a quantitative analysis of microglial density, morphology, and GPR34 expression in the medial temporal lobe cortex (MTLC) of elderly human body and tissue donors across the AD spectrum. Using fluorescence in situ hybridization and immunolabeling, we analyzed 187,670 microglial cells and correlated microglial parameters with the severity and spatial proximity of Aβ plaques and tau inclusions. In parallel, we analyzed human single-nucleus RNA sequencing data from 236,002 cells to assess GPR34 expression across microglial subtypes, brain regions, and neuropathological stages. Microglial density and overall morphology in the MTLC were largely preserved, independent of local Aβ or hyperphosphorylated tau burdens. Apart from a moderate shortening of microglial processes in the immediate vicinity of Aβ plaques, no consistent pathology-associated morphological changes were detected. GPR34 expression showed pronounced cell-to-cell variability and differed across microglial subtypes and brain regions, but neither expression intensity nor the proportion of GPR34-positive microglia correlated consistently with Braak stage or Thal phase. These findings suggest that GPR34 regulation in human microglia is highly context-dependent and shaped by regional and cellular heterogeneity rather than AD-associated pathology alone.

Supplementary Information: The online version contains supplementary material available at 10.1007/s00401-026-03035-0.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Data availability

All data and materials generated in this study, including microscopy images and analytical outputs, are available from the corresponding author upon reasonable request. The snRNA-seq data were obtained from the Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) consortium and are publicly available through the Allen Institute Brain Map data portal (https://brain-map.org/consortia/sea-ad/our-data). The microglia and immune cell dataset is accessible through the SEA-AD data repository at https://sea-ad-single-cell-profiling.s3.amazonaws.com/index.html#Microglia-and-Immune-for-AAIC/. Custom analysis scripts used for data processing and visualization are available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Springer Science+Business Media

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 5 keywords, 12 MeSH terms, 1 funder, 129 references.

Cite

This paper

Seiffer, S., Rotter, J., Brendler, J., Ricken, A., Detzer, Z., Braune, M., Schöneberg, T., Schulz, A., Winter, K., & Bechmann, I. (2026). Expression of GPR34 in microglia remains stable in human Alzheimer's disease. Acta neuropathologica, 151(1), 66. https://doi.org/10.1007/s00401-026-03035-0

BibTeX

@article{seiffer2026expression,
author = {Seiffer, Sophie and Rotter, Jonas and Brendler, Jana and Ricken, Albert and Detzer, Zoe and Braune, Max and Schöneberg, Torsten and Schulz, Angela and Winter, Karsten and Bechmann, Ingo},
title = {{Expression of GPR34 in microglia remains stable in human Alzheimer's disease}},
journal = {Acta neuropathologica},
year = {2026},
month = jun,
volume = {151},
number = {1},
pages = {66},
publisher = {Springer Science+Business Media},
issn = {0001-6322},
doi = {10.1007/s00401-026-03035-0},
url = {https://doi.org/10.1007/s00401-026-03035-0},
pmid = {42295430},
pmcid = {PMC13269318}
}

RIS

TY - JOUR
AU - Seiffer, Sophie
AU - Rotter, Jonas
AU - Brendler, Jana
AU - Ricken, Albert
AU - Detzer, Zoe
AU - Braune, Max
AU - Schöneberg, Torsten
AU - Schulz, Angela
AU - Winter, Karsten
AU - Bechmann, Ingo
TI - Expression of GPR34 in microglia remains stable in human Alzheimer's disease
T2 - Acta neuropathologica
J2 - Acta Neuropathol
PY - 2026
DA - 2026/06/15
VL - 151
IS - 1
SP - 66
SN - 0001-6322
PB - Springer Science+Business Media
DO - 10.1007/s00401-026-03035-0
UR - https://doi.org/10.1007/s00401-026-03035-0
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s00401-026-03035-0",
"type": "article-journal",
"title": "Expression of GPR34 in microglia remains stable in human Alzheimer's disease",
"container-title": "Acta neuropathologica",
"author": [
{
"family": "Seiffer",
"given": "Sophie"
},
{
"family": "Rotter",
"given": "Jonas"
},
{
"family": "Brendler",
"given": "Jana"
},
{
"family": "Ricken",
"given": "Albert"
},
{
"family": "Detzer",
"given": "Zoe"
},
{
"family": "Braune",
"given": "Max"
},
{
"family": "Schöneberg",
"given": "Torsten"
},
{
"family": "Schulz",
"given": "Angela"
},
{
"family": "Winter",
"given": "Karsten"
},
{
"family": "Bechmann",
"given": "Ingo"
}
],
"container-title-short": "Acta Neuropathol",
"volume": "151",
"issue": "1",
"page": "66",
"DOI": "10.1007/s00401-026-03035-0",
"PMID": "42295430",
"PMCID": "PMC13269318",
"ISSN": "0001-6322",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1007/s00401-026-03035-0",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
15
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fnins.2021.778822
Synapses, Microglia, and Lipids in Alzheimer's Disease.
Journal: Frontiers in neuroscience
In common: Alzheimer's / dementia, cellular / molecular, 12 references
[2] doi:10.1038/s41398-026-03978-8 [code]
Identification of suicide brain transcriptomic signatures using meta-analysis of multiple cohorts.
Journal: Translational psychiatry
In common: cellular / molecular, 9 references
[3] doi:10.3390/cells12242824
Microglial Senescence and Activation in Healthy Aging and Alzheimer's Disease: Systematic Review and Neuropathological Scoring.
Journal: Cells
In common: histology / microscopy, Alzheimer's / dementia, cellular / molecular, 10 references
[4] doi:10.14336/ad.2025.0409 [code]
Layer-Specific Colocalization of Microglia with Amyloid Plaques in the Middle Temporal Gyrus Predicts Cognitive Decline in Alzheimer's Disease.
Journal: Aging and disease
In common: histology / microscopy, Alzheimer's / dementia, cellular / molecular, 9 references
[5] doi:10.1038/s41467-024-49790-0 [code]
Single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease.
Journal: Nature communications
In common: Alzheimer's / dementia, cellular / molecular, 9 references
[6] doi:10.14336/ad.2024.0429 [code]
Systematic Analysis of Biological Processes Reveals Gene Co-expression Modules Driving Pathway Dysregulation in Alzheimer's Disease.
Journal: Aging and disease
In common: Alzheimer's / dementia, cellular / molecular, 9 references
[7] doi:10.1186/s12974-023-02987-4 [code]
Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer's disease.
Journal: Journal of neuroinflammation
In common: Alzheimer's / dementia, cellular / molecular, 9 references
[8] doi:10.1007/s12035-025-04997-0
Decoding Alzheimer's Disease: Single-Cell Sequencing Uncovers Brain Cell Heterogeneity and Pathogenesis.
Journal: Molecular neurobiology
In common: histology / microscopy, Alzheimer's / dementia, cellular / molecular, 8 references
[9] doi:10.1186/s13195-025-01944-y [code]
Exploring cellular heterogeneity: single-cell and spatial transcriptomics of Alzheimer's disease brains and iPSC-derived microglia.
Journal: Alzheimer's research & therapy
In common: histology / microscopy, Alzheimer's / dementia, cellular / molecular, 7 references
[10] doi:10.1038/s41593-026-02267-3 [code]
Spatial proteomic analysis in human Alzheimer's disease brains enables identification of microenvironment-dependent microglial cell states.
Journal: Nature neuroscience
In common: Alzheimer's / dementia, cellular / molecular, 8 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.